How to Get Semaglutide Prescribed Online — Without the Office Visit

Semaglutide is the active pharmaceutical ingredient in the FDA-approved drugs Ozempic® and Wegovy® and is widely prescribed for weight loss in the brand-name forms. Getting a prescription for a semaglutide-based therapy no longer requires an in-person visit to a specialist. Licensed telehealth providers can evaluate you and write a prescription through a secure online consultation.

The online prescription process is straightforward. You complete a health assessment that covers your weight, height, medical history, current medications, and health goals. A licensed physician or nurse practitioner reviews your information, determines whether GLP-1 therapy is clinically appropriate, and selects your starting dose. If approved, your medication is prepared by a licensed pharmacy and shipped directly to your home.

Weight Method's compounded program is priced at $154 per month for compounded semaglutide. The pricing includes the medication, the medical evaluation, ongoing provider supervision, and monthly home delivery — bundled into one predictable subscription rather than separate visit and pharmacy charges. Compounded semaglutide is not FDA-approved and is not reviewed by the FDA for safety, effectiveness, or quality.

The FDA-approved brand product Wegovy is indicated for chronic weight management in adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition. These conditions include type 2 diabetes, hypertension, high cholesterol, obstructive sleep apnea, and cardiovascular disease. At Weight Method, our providers follow these established clinical criteria when evaluating patients.

Semaglutide is often considered for patients who have tried diet and exercise without achieving lasting results. It works by acting on GLP-1 receptors to reduce appetite and slow gastric emptying, which can support weight management alongside lifestyle changes.

There are important contraindications. Semaglutide should not be used by individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2). It is not recommended during pregnancy or breastfeeding. Patients with a history of pancreatitis should discuss risks with their provider. These are the same screening criteria used by in-person providers — the evaluation is equally thorough whether conducted online or in a clinic.

Semaglutide follows a standard dose escalation schedule designed to minimize gastrointestinal side effects. Treatment begins at 0.25 mg per week for the first four weeks. This is a sub-therapeutic dose intended to let your body acclimate to the medication. The dose then increases monthly: 0.5 mg, 1.0 mg, 1.7 mg, and finally the maintenance dose of 2.4 mg weekly.

Your online provider manages this escalation based on your individual response. If you experience significant nausea or other GI side effects at a particular dose, your provider may slow the escalation — staying at a lower dose for additional weeks before increasing. This personalized approach is a hallmark of quality telehealth care and a reason why ongoing provider access matters more than just the initial prescription.

Most patients begin noticing appetite reduction within the first two weeks, even at the starting dose. Clinically meaningful weight loss — typically defined as 5% or more of body weight — usually occurs within the first three months. Maximum weight loss is generally achieved between 12 and 18 months of continuous treatment. At Weight Method, your provider tracks your progress and adjusts your plan throughout the treatment journey.

Patients evaluating telehealth GLP-1 programs commonly ask how the online pathway works compared to the traditional route. Even when a brand-name medication is run through insurance, many patients face prior authorization hurdles, step therapy requirements, and significant copays. Some insurance plans do not cover weight loss medications at all, and the office-visit-then-pharmacy sequence adds scheduling friction.

Weight Method's compounded program is priced at $154 per month for compounded semaglutide, including the medication, provider evaluation, ongoing clinical support, and monthly home delivery. Compounded semaglutide is not FDA-approved and is not reviewed by the FDA for safety, effectiveness, or quality. Compounded preparations are prepared by licensed compounding pharmacies under a prescription and are not interchangeable with the FDA-approved branded products in a regulatory sense.

Beyond pricing predictability, the online model simplifies the process. There is no need to schedule a separate in-person appointment, obtain a paper prescription, and then coordinate with a pharmacy. With Weight Method, the medical evaluation, prescribing, and pharmacy fulfillment are integrated into a single experience. Your medication arrives at your door each month without you having to manage any of the logistics.

The first few weeks on semaglutide bring noticeable changes. Most patients report a significant reduction in appetite and food cravings within 7-14 days of their first injection. The concept of "food noise" — the persistent mental preoccupation with eating — tends to quiet considerably. Many patients describe this as the most transformative aspect of the medication.

Side effects during the initial weeks are common but typically manageable. The most frequently reported side effects are nausea, constipation, diarrhea, and mild abdominal discomfort. These tend to be most pronounced during dose increases and generally improve as your body adjusts. Eating smaller meals, staying hydrated, and avoiding high-fat foods can help minimize GI symptoms. Your Weight Method provider is available to help manage any side effects you experience.

Over the following months, you can expect steady, progressive weight loss. In clinical trials, patients on semaglutide 2.4 mg lost an average of about 1-2% of their body weight per month during the active weight loss phase. For a 250-pound person, that translates to roughly 2.5-5 pounds per month. While individual results vary, the trajectory is consistently downward when combined with moderate lifestyle modifications. Your provider monitors your progress and ensures your treatment remains on track.